MHC class II genotype and the control of viremia in HIV-1-infected individuals on highly active antiretroviral therapy.
作者信息
Blankson J N, Siliciano R F
机构信息
Johns Hopkins University School of Medicine, Department of Medicine, Baltimore, Maryland, USA.
出版信息
J Clin Invest. 2001 Mar;107(5):549-51. doi: 10.1172/JCI12430.
Abstract
摘要
相似文献
1
MHC class II genotype and the control of viremia in HIV-1-infected individuals on highly active antiretroviral therapy.MHC II类基因型与接受高效抗逆转录病毒治疗的HIV-1感染个体的病毒血症控制
J Clin Invest. 2001 Mar;107(5):549-51. doi: 10.1172/JCI12430.
2
HIV-specific CD4+ T cells and viremia: who's in control?HIV特异性CD4+ T细胞与病毒血症：究竟谁在掌控？
Trends Immunol. 2006 Mar;27(3):119-24. doi: 10.1016/j.it.2006.01.004. Epub 2006 Feb 3.
3
HIV-1-specific CD4+ T lymphocyte turnover and activation increase upon viral rebound.病毒反弹时，HIV-1特异性CD4 + T淋巴细胞的更新和活化增加。
J Clin Invest. 2005 Feb;115(2):443-50. doi: 10.1172/JCI23084.
4
Association between cellular human immunodeficiency virus DNA level and immunological parameters in patients with undetectable plasma viremia level during highly active antiretroviral therapy.高效抗逆转录病毒治疗期间血浆病毒血症水平检测不到的患者，其细胞内人类免疫缺陷病毒DNA水平与免疫参数之间的关联
J Clin Microbiol. 2005 Dec;43(12):6183-5. doi: 10.1128/JCM.43.12.6183-6185.2005.
5
Seroreversion of HIV antibodies in patients with prolonged suppression of viraemia under HAART.在高效抗逆转录病毒治疗（HAART）下病毒血症长期受到抑制的患者中，HIV抗体血清学逆转。
AIDS. 2006 Jun 26;20(10):1460-2. doi: 10.1097/01.aids.0000233584.10209.43.
6
7
Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection.在慢性HIV感染中，通过结构化治疗中断刺激HIV特异性细胞免疫未能增强病毒控制。
Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13747-52. doi: 10.1073/pnas.202372199. Epub 2002 Oct 7.
8
More on stopping antiretroviral therapy.
AIDS Clin Care. 1999 Dec;11(12):100.
9
Long-term immunological benefit in patients with discordant responses to therapy depends on both level of viremia and duration of rebound.
J Infect Dis. 2002 Aug 1;186(3):445-6. doi: 10.1086/341461.
10
Biomarkers of HIV replication.HIV 复制的生物标志物。
Curr Opin HIV AIDS. 2010 Nov;5(6):491-7. doi: 10.1097/COH.0b013e32833f206f.
引用本文的文献
1
Human Immunotypes Impose Selection on Viral Genotypes Through Viral Epitope Specificity.人类免疫型通过病毒表位特异性对病毒基因型施加选择。
J Infect Dis. 2021 Dec 15;224(12):2053-2063. doi: 10.1093/infdis/jiab253.
2
Sequential emergence and clinical implications of viral mutants with K70E and K65R mutation in reverse transcriptase during prolonged tenofovir monotherapy in rhesus macaques with chronic RT-SHIV infection.在慢性RT-SHIV感染的恒河猴长期接受替诺福韦单药治疗期间，逆转录酶中具有K70E和K65R突变的病毒突变体的相继出现及其临床意义。
Retrovirology. 2007 Apr 6;4:25. doi: 10.1186/1742-4690-4-25.
本文引用的文献
1
Role for HLA class II molecules in HIV-1 suppression and cellular immunity following antiretroviral treatment.人类白细胞抗原II类分子在抗逆转录病毒治疗后HIV-1抑制及细胞免疫中的作用
J Clin Invest. 2001 Feb;107(4):505-17. doi: 10.1172/JCI11275.
2
Proliferative responses to human immunodeficiency virus type 1 (HIV-1) antigens in HIV-1-infected patients with immune reconstitution.免疫重建的HIV-1感染患者对1型人类免疫缺陷病毒（HIV-1）抗原的增殖反应。
J Infect Dis. 2001 Feb 15;183(4):657-61. doi: 10.1086/318545. Epub 2001 Jan 12.
3
Immune control of HIV-1 after early treatment of acute infection.急性感染早期治疗后HIV-1的免疫控制
Nature. 2000 Sep 28;407(6803):523-6. doi: 10.1038/35035103.
4
HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors.HLA B*5701与HIV感染的长期非进展者亚组中病毒复制的受限高度相关。
Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2709-14. doi: 10.1073/pnas.050567397.
5
Effect of combination antiretroviral therapy on T-cell immunity in acute human immunodeficiency virus type 1 infection.联合抗逆转录病毒疗法对急性1型人类免疫缺陷病毒感染中T细胞免疫的影响。
J Infect Dis. 2000 Jan;181(1):121-31. doi: 10.1086/315202.
6
Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy.高效抗逆转录病毒疗法抑制病毒血症后，1型人类免疫缺陷病毒特异性细胞毒性T淋巴细胞效应和记忆反应水平下降。
J Virol. 1999 Aug;73(8):6721-8. doi: 10.1128/JVI.73.8.6721-6728.1999.
7
Consistent associations of HLA class I and II and transporter gene products with progression of human immunodeficiency virus type 1 infection in homosexual men.人类免疫缺陷病毒1型感染在男同性恋者中进展与HLA I类和II类以及转运蛋白基因产物的持续关联。
J Infect Dis. 1999 Aug;180(2):299-309. doi: 10.1086/314862.
8
Control of HIV despite the discontinuation of antiretroviral therapy.尽管停止了抗逆转录病毒治疗，但HIV仍得到控制。
N Engl J Med. 1999 May 27;340(21):1683-4. doi: 10.1056/NEJM199905273402114.
9
HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression.在大多数处于活跃HIV-1感染期的个体中可检测到HIV-1特异性CD4+ T细胞，但随着病毒抑制时间延长，这些细胞数量会下降。
Nat Med. 1999 May;5(5):518-25. doi: 10.1038/8400.
10
HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage.人类白细胞抗原与人类免疫缺陷病毒1型：杂合子优势及B*35-Cw*04劣势
Science. 1999 Mar 12;283(5408):1748-52. doi: 10.1126/science.283.5408.1748.
Zotero 插件